128 results
Page 2 of 7
8-K
EX-10.1
33j cffpux
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
l8nqpxzkp8022kk1xtrd
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
D
jahtn40mc 036h
19 Feb 21
$10.24M in equity / options, sold $10.24M, 18 investors
9:26am
8-K
EX-10.1
o79muwe
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am